633 related articles for article (PubMed ID: 24923364)
21. [Can any heart be preconditioned? Influence of aging and comorbidities on cardioprotection].
Bilińska M
Kardiol Pol; 2011; 69 Suppl 3():85-8. PubMed ID: 22125209
[TBL] [Abstract][Full Text] [Related]
22. Gasotransmitters and noble gases in cardioprotection: unraveling molecular pathways for future therapeutic strategies.
Pagliaro P; Weber NC; Femminò S; Alloatti G; Penna C
Basic Res Cardiol; 2024 Jun; ():. PubMed ID: 38878210
[TBL] [Abstract][Full Text] [Related]
23. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
Vinten-Johansen J; Shi W
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
[TBL] [Abstract][Full Text] [Related]
24. Troxerutin Preconditioning and Ischemic Postconditioning Modulate Inflammatory Response after Myocardial Ischemia/Reperfusion Injury in Rat Model.
Badalzadeh R; Baradaran B; Alihemmati A; Yousefi B; Abbaszadeh A
Inflammation; 2017 Feb; 40(1):136-143. PubMed ID: 27807687
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen sulfide post-conditioning preserves interfibrillar mitochondria of rat heart during ischemia reperfusion injury.
Banu SA; Ravindran S; Kurian GA
Cell Stress Chaperones; 2016 Jul; 21(4):571-82. PubMed ID: 26951457
[TBL] [Abstract][Full Text] [Related]
26. Ranolazine triggers pharmacological preconditioning and postconditioning in anesthetized rabbits through activation of RISK pathway.
Efentakis P; Andreadou I; Bibli SI; Vasileiou S; Dagres N; Zoga A; Lougiakis N; Kremastinos DT; Iliodromitis EK
Eur J Pharmacol; 2016 Oct; 789():431-438. PubMed ID: 27492365
[TBL] [Abstract][Full Text] [Related]
27. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
[TBL] [Abstract][Full Text] [Related]
28. Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
Andreadou I; Iliodromitis EK; Lazou A; Görbe A; Giricz Z; Schulz R; Ferdinandy P
Br J Pharmacol; 2017 Jun; 174(12):1555-1569. PubMed ID: 28060997
[TBL] [Abstract][Full Text] [Related]
29. Cardioprotection: chances and challenges of its translation to the clinic.
Heusch G
Lancet; 2013 Jan; 381(9861):166-75. PubMed ID: 23095318
[TBL] [Abstract][Full Text] [Related]
30. Delayed postconditioning in the mouse heart in vivo.
Roubille F; Franck-Miclo A; Covinhes A; Lafont C; Cransac F; Combes S; Vincent A; Fontanaud P; Sportouch-Dukhan C; Redt-Clouet C; Nargeot J; Piot C; Barrère-Lemaire S
Circulation; 2011 Sep; 124(12):1330-6. PubMed ID: 21875909
[TBL] [Abstract][Full Text] [Related]
31. Involvement of exogenous H2S in recovery of cardioprotection from ischemic post-conditioning via increase of autophagy in the aged hearts.
Chen J; Gao J; Sun W; Li L; Wang Y; Bai S; Li X; Wang R; Wu L; Li H; Xu C
Int J Cardiol; 2016 Oct; 220():681-92. PubMed ID: 27393850
[TBL] [Abstract][Full Text] [Related]
32. Platelets and Cardioprotection: The Role of Nitric Oxide and Carbon Oxide.
Russo I; Barale C; Melchionda E; Penna C; Pagliaro P
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047079
[TBL] [Abstract][Full Text] [Related]
33. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
[TBL] [Abstract][Full Text] [Related]
34. Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.
Lochner A; Marais E; Genade S; Huisamen B; du Toit EF; Moolman JA
Cardiovasc J Afr; 2009; 20(1):43-51. PubMed ID: 19287816
[TBL] [Abstract][Full Text] [Related]
35. The role of mitochondrial reactive oxygen species, NO and H
Andreadou I; Schulz R; Papapetropoulos A; Turan B; Ytrehus K; Ferdinandy P; Daiber A; Di Lisa F
J Cell Mol Med; 2020 Jun; 24(12):6510-6522. PubMed ID: 32383522
[TBL] [Abstract][Full Text] [Related]
36. Heat shock protein 70: A promising therapeutic target for myocardial ischemia-reperfusion injury.
Song YJ; Zhong CB; Wang XB
J Cell Physiol; 2019 Feb; 234(2):1190-1207. PubMed ID: 30132875
[TBL] [Abstract][Full Text] [Related]
37. Myocardial ischaemia reperfusion injury: the challenge of translating ischaemic and anaesthetic protection from animal models to humans.
Xia Z; Li H; Irwin MG
Br J Anaesth; 2016 Sep; 117 Suppl 2():ii44-ii62. PubMed ID: 27566808
[TBL] [Abstract][Full Text] [Related]
38. Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo.
Li J; Loukili N; Rosenblatt-Velin N; Pacher P; Feihl F; Waeber B; Liaudet L
PLoS One; 2013; 8(7):e70331. PubMed ID: 23875026
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.
Przyklenk K
Drugs Aging; 2011 May; 28(5):331-43. PubMed ID: 21542657
[TBL] [Abstract][Full Text] [Related]
40. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.
Polhemus DJ; Lefer DJ
Circ Res; 2014 Feb; 114(4):730-7. PubMed ID: 24526678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
